Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Embolx
company
About
Embolx is a medical device start-up that manufactures and sells novel embolization microcatheters to treat cancer.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2M
- Industries
- Health Care,Manufacturing,Medical Device
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Embolx is a venture-backed start-up in Silicon Valley that is developing and commercializing unique catheter-based systems that enable a breakthrough in minimally invasive localized cancer therapy. Embolx devices use pressure regulation to eliminate non-target delivery and increase drug distribution in the tumor using an advanced method known as Low Pressure Embolization (LPE).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$2.26M
Embolx has raised a total of
$2.26M
in funding over 2 rounds. Their latest funding was raised on
Apr 6, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 6, 2018 | Grant | $2M | 1 |
National Institutes of Health
|
— | Detail |
| Jun 3, 2014 | Grant | $269.92K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Embolx is funded by 2 investors.
National Institutes of Health
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
